Sort
64,565 grants matching “drug discovery”
Chromatin and Herpes Simplex Virus Latency
$493,293David M Knipe · Harvard Medical School · R01 · FY2012 · AI
Amorphous Pharmaceutical Product Development Using Containerless Methods
$493,251Richard Johann Weber · Materials Development, Inc. · R44 · FY2020 · GM
New Bond Disconnections in the Streamlined Synthesis of Complex Bioactive Molecules
$493,243Thomas John Maimone · University Of California Berkeley · R35 · FY2025 · GM
Vesicle-mediated drug resistance of Candida albicans biofilm
$493,243David R Andes · University Of Wisconsin-Madison · R01 · FY2024 · AI
Small molecule biomarkers for tuberculosis treatment, relapse, and cure
$493,237John T Belisle · Colorado State University · U18 · FY2011 · FD
Small molecule biomarkers for tuberculosis treatment, relapse, and cure
$493,237John T Belisle · Colorado State University · U18 · FY2010 · FD
Cell biology of vasopressin-induced water channels
$493,218Dennis Brown · Massachusetts General Hospital · R01 · FY2015 · DK
Cell biology of vasopressin-induced water channels
$493,218Dennis Brown · Massachusetts General Hospital · R01 · FY2014 · DK
Chromatin and the Lytic/Latent Balance
$493,157David M Knipe · Harvard Medical School · P01 · FY2017 · AI
Derivation of lung epithelia from iPS cells for advanced disease modeling
$493,152Darrell N. Kotton · Boston University Medical Campus · R01 · FY2019 · HL
Metagenomic detection of emerging viruses in the blood supply
$493,106Eric L. Delwart · Vitalant · R01 · FY2012 · HL
NSAID-Phosphatidylcholine Association: Insight in GI Ulcer Pathogenesis/Therapy
$493,076Lenard M Lichtenberger · University Of Texas Hlth Sci Ctr Houston · RC1 · FY2009 · DK
High-Throughput Platform for Identifying Stem Cell Toxicity
$492,972Jonathan S. Dordick · Rensselaer Polytechnic Institute · R01 · FY2014 · ES
Eeyarestatin I inhibits the p97 ATPase to induce tumor cell apoptosis
$492,938Yihong Ye · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2009 · DK
Ensemble Networks for Allosteric Drug Design
$492,900Kelly Marie Thayer · Wesleyan University · R15 · FY2021 · GM
Inhibition of HeptosyltransferaseI for the treatment of Gram-negative bacterial infection
$492,900Erika A Taylor · Wesleyan University · R15 · FY2015 · AI
OTHER FUNCTIONS TAS::75 0849::TAS; THIS MODIFICATION ADDS FUNDING FOR WA'S 2 AND
$492,866Vladimir Rudchenko · Alchem Laboratories Corporation · N02 · FY2016 · CA
Glial and Synaptic Functions in Major Depression
$492,855Chadi Abdallah · Yale University · R01 · FY2019 · MH
Glial and Synaptic Functions in Major Depression
$492,855Chadi Abdallah · Yale University · R01 · FY2020 · MH
Influence of APOE Genotype on the neurodegenerative sequelae of repetitive mild TBI in an hTau mouse model.
$492,853Fiona C. Crawford · Roskamp Institute, Inc. · R56 · FY2019 · NS
Neural hierarchy in the modulation of ingestive behavior
$492,813Harvey J Grill · University Of Pennsylvania · R01 · FY2014 · DK
Project 2: Large ncRNAs and Epigenetic Regulation in Pluripotency
$492,811John Louis Rinn · Harvard University · P01 · FY2011 · GM
Core C - Drug Discovery and Development Core (DDDC)
$492,809Paul D. Robbins · Mayo Clinic Rochester · P01 · FY2025 · AG
Core A - Administrative and Systems Biology of Aging Core (ASBC)
$492,809Nathan K Lebrasseur · Mayo Clinic Rochester · P01 · FY2025 · AG
Targeting the endometrial stem cell niche inendometriosis
$492,806Diana Monsivais · Baylor College Of Medicine · R01 · FY2023 · HD